A. Sinha (Amsterdam, Netherlands), E. Barreiro Portela (Barcelona, Spain)
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
C. Chang (Beijing, China), Y. Liang (Beijing, China), J. Wang (Beijing, China), Y. Sun (Beijing, China), W. Yao (Beijing, China)
|  |
Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma
V. Kalinauskaite-Zukauske (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Association between COPD bronchial brush microbiome-determined ?Proteobacteria:Firmicutes (G:F) ratio and GOLD grade and symptoms
M. Yavari Ramsheh (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), L. Ziegler-Heitbrock (Gauting, Germany), I. Gut (Barcelona, Spain), D. Singh (Manchester, United Kingdom), C. Brightling (Leicester, United Kingdom)
|  |
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
B. Zhou (Xi'an, China), J. She (Xi'an, China)
| |
Particles in exhaled air (PExA) method - repeatability in children
M. Juusela (Helsinki, Finland), V. Aaltonen (Helsinki, Finland), S. Sarna (Helsinki, Finland), E. Qvist (Helsinki, Finland), K. Malmström (Helsinki, Finland)
| |
Relationship between salivary markers of oxidative stress (OS) and different levels of control of bronchial asthma (BA).
I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), . Tush (Nizhny Novgorod, Russian Federation), N. Kubysheva (Kazan, Russian Federation), M. Izvolenskaya (Nizhny Novgorod, Russian Federation), T. Eliseeva (Nizhny Novgorod, Russian Federation), T. Kolegova (Nizhny Novgorod, Russian Federation), V. Kurashina (Nizhny Novgorod, Russian Federation), . Khaletskaya (Nizhny Novgorod, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation)
| |
Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD
Y. Suzuki (Fukushima, Japan), J. Saito (Fukushima, Japan), M. Rikimaru (Fukushima, Japan), M. Uematsu (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), S. Sato (Fukushima, Japan), T. Kawamata (Fukushima, Japan), . Togawa (Fukushima, Japan), . Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), N. Fukuhara (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan)
| |
MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
G. Becher (Bernau, Germany), R. Purkhart (Oberlichtenau, Germany), T. Junghans (Aue, Germany), R. Graupner (Geyer, Germany)
| |
Comparing sputum rheology and spirometry as pathological markers in respiratory diseases
J. Patarin (Grenoble, France), É. Ghiringhelli (Grenoble, France), G. Darsy (Grenoble, France), M. Obamba (Grenoble, France), M. Robert de Saint Vincent (Grenoble, France), J. Cracowski (Grenoble, France), B. Camara (Grenoble, France), S. Quétant (Grenoble, France), J. Quésada (Grenoble, France), C. Cracowski (Grenoble, France)
| |
Comparison of artificial neural networks and a standardized questionnaire for the diagnosis of COPD.
A. Bastidas Goyes (Chía,, Colombia), M. Oviedo Otero (ChiáChía,, Colombia), M. Buitrago Pedraza (ChiáChía,, Colombia), N. Sáenz Romero (ChiáChía,, Colombia), D. Mainero Manotas (ChiáChía,, Colombia), L. Zambrano Reyes (ChiáChía,, Colombia), J. Moreno (ChiáChía,, Colombia)
| |
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
O. Holz (Hannover, Germany), B. Waschki (Grosshansdorf, Germany), S. Schuchardt (Hannover, Germany), H. Watz (Grosshansdorf, Germany), O. Fuchs (Bern, Switzerland), E. Von Mutius (Munich, Germany), G. Hansen (Hannover, Germany), M. Kopp (Luebeck, Germany), K. Rabe (Grosshansdorf, Germany), J. Hohlfeld (Hannover, Germany), T. Bahmer (Grosshansdorf, Germany)
| |
EXhaled Hydrogen peroxide As a marker of Lung diseasE – the EXHALE 1A study
M. Jones (Portsmouth, United Kingdom), D. Neville (Portsmouth, United Kingdom), J. Gates (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), C. Fogg (Portsmouth, United Kingdom), M. Amos-Lyons (Portsmouth, United Kingdom), M. Chauhan (Portsmouth, United Kingdom), S. Begum (Portsmouth, United Kingdom), J. Longstaff (Portsmouth, United Kingdom), J. Winter (Portsmouth, United Kingdom), J. Williams (Hartpury, United Kingdom), J. Shute (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom)
| |
What influence surfactant composition?
A. Olin (Gothenburg, Sweden), S. Kokelj (Gothenburg, Sweden), E. Mirgorodskaya (Gothenburg, Sweden), C. Jansson (Gothenburg, Sweden), M. Holm (Gothenburg, Sweden), L. Hussein (Gothenburg, Sweden), B. Bake (Gothenburg, Sweden)
| |
The 6 Gene Signature in Whole Sampled Sputum provides Clinically Feasible Inflammatory Phenotyping of Asthma
L. Frøssing (Copenhagen, Denmark), D. Kjærsgaard Klein (Copenhagen, Denmark), K. Baines (Newcastle, Australia), P. Gibson (Newcastle, Australia), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
Differential measurement of exhaled breath temperature allows characterization of the spread of inflammation in airways diseases
S. Gonzalez-Diaz (Monterrey,Nuevo Leon , Mexico), R. Guzman-Avilan (Monterrey,Nuevo Leon , Mexico), R. Villarreal-Gonzalez (Monterrey,Nuevo Leon , Mexico), C. De Lira-Quezada (Monterrey,Nuevo Leon , Mexico), T. Popov (Sofia, Bulgaria), I. Ansotegui-Zubeldia (Bilbao, Spain), M. Sanchez-Borges (Caracas, Venezuela)
| |
Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort
J. Sand (Herlev, Denmark), S. Rønnow (Herlev, Denmark), N. Gudmann (Herlev, Denmark), L. Langholm (Herlev, Denmark), M. Karsdal (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), R. Tal-Singer (Collegeville, PA, United States of America), B. Miller (Collegeville, PA, United States of America), J. Vestbo (Manchester, United Kingdom), D. Leeming (Herlev, Denmark)
| |
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Y. Wu (Chengdu, China), J. Qin (Chengdu, China), Y. Shen (Chengdu, China), H. Wang (Chengdu, China), F. Wen (Chengdu, China)
| |
Diurnal variation and repeatability of surfactant protein A and albumin in exhaled particles
S. Kokelj (Gothenburg, Sweden), J. Kim (Gothenburg, Sweden), M. Andersson (Gothenburg, Sweden), B. Bake (Gothenburg, Sweden), L. Hussain (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden)
| |